Delivery Order SPE2DB20D3103-SPE2DB25FQ2A9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, to supply Prezista 800 mg tablets (30-count units) to the Defense Logistics Agency's Medical Supply Chain. The contract is valued at approximately $12.7K under firm fixed pricing with a completion date of September 9, 2025. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery...
- This delivery order, valued at $4,654.38, awards AmerisourceBergen Drug Corp the supply of Prezista 800 mg tablets (30-count units) under a firm fixed price arrangement. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of August 5, 2025. The award supports the Defense Logistics Agency's Medical Supply Chain, a key component of federal medical procurement for military and veteran healthcare systems. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PREZISTA 800 MG TABLET 30S. The contract has a ceiling value of $1,392.33 and a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,758.54 order is for the supply of PREZISTA 800 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of January 25, 2024. AmerisourceBergen Drug Corp provides a range of pharmaceutical and medical supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PREZISTA 800 MG TABLET 30S medication. The contract has a completion date of March 5, 2024 and a potential value of $2,571.19. Amerisourcebergen Drug Corp is the prime contractor for this contract, which does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,998.53, is for the delivery of Prezista 800 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,604.12 firm fixed price contract is for the delivery of PREZISTA 800 MG tablets. It is not associated with a set-aside program. The contract has an ultimate completion date of January 16, 2024 and was awarded on January 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $3,866.25, is for the delivery of PREZISTA 800 MG TABLET 30S, a prescription pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date for this award is September 10, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $29,002.86 firm-fixed-price delivery order is for the supply of PREZISTA 600 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,859.03, is for the delivery of 4565510818 PREZISTA 800 MG TABLET 30S. It is a firm-fixed-price delivery order with a completion date of August 21, 2024. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2A9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Prezista 800 mg tablets in a 30-count quantity, with a ceiling value of $1,411.83. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract history demonstrates consistent capability in meeting defense pharmaceutical requirements across multiple therapeutic domains, positioning it as a key supplier within the DLA's Medical Supply Chain network serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/8/25 |